SBI Life Insurance is a joint venture life insurance company between State Bank of India and BNP Paribas Cardif. Its individual plans include unit linked plans, child plans, retirement plans, protection plans and savings plans. Its group plans include Corporate Solutions, Group Loan Protection Products and Group Micro Insurance Plans. Its corporate solutions include retirement solutions, such as SBI Life-Kalyan ULIP Plus. SBI life-CapAssure Gold and SBI life-Swarna Jeevan, and group protection plans, such as SBI Life-Pradhan Mantri Jeevan Jyoti Bima Yojana, SBI Life-Sampoorn Suraksha and SBI Life-Suraksha Plus.

stock-detail

SHORT TERM PERSPECTIVE

Company SBI Life Insurance Company Ltd.
Recommendation Accumulate (Rs.850-Rs.860)
CMP Rs 864.40
Stop Loss (SL) Rs 810
Target Price Rs 950
Time Horizon 2-4 Weeks

 

stock-graph

Intermediate and short term trend is up in this stock. The stock has continuously been making higher top and higher bottom formation on the daily chart. After a moil correction, the stock has taken support from its 200 Day EMA. The stock has also given a breakout from a Flag pattern which is Bullish in Nature. Increase in volume and positive diversion from oscillator indicate that it can move higher from current levels so one can accumulate the stock between (Rs 850-860) With a stop loss of Rs. 810 on closing basis and respected target seems Rs 950. Time frame should be 2-4 weeks.

DISCLOSURE IN PURSUANCE OF SECTION 19 OF SEBI (RA) REGULATION 2014

Elite Wealth Advisors Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Advisors Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as read more


For Daily Share Market Updates, Daily debt market review, Market Research Analysis reports, Weekly Techno-Funda Report, Fundamental Analysis Report, Monthly Recommended stock Picks, Equity Trading Tips, Upcoming IPO/NFO/Bonds/Ncd’s updates & other related information Subscribe our research plan